Laddar...
Citalopram reduces aggregation of ATXN3 in a YAC transgenic mouse model of Machado-Joseph disease
Machado-Joseph disease, also known as Spinocerebellar ataxia type 3, is a fatal polyglutamine disease with no disease-modifying treatment. The selective serotonin reuptake inhibitor citalopram was shown in nematode and mouse models to be a compelling repurposing candidate for Machado-Joseph disease...
Sparad:
| I publikationen: | Mol Neurobiol |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6417975/ https://ncbi.nlm.nih.gov/pubmed/30187384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12035-018-1331-2 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|